Related Experiment Video
Updated: Jun 15, 2026

A Modified Co-Culture System for Understanding Granulosa-Theca Cell Interactions in the Bovine Ovary
Published on: September 19, 2025
FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells
Mira Park1, Eunkyoung Shin, Miae Won
1Department of Biomedical Science, College of Life Science, CHA University, Seongnam 463-836, Korea.
Abstract:
Mutations in FOXL2 are responsible for blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) type I, in which affected women exhibit premature ovarian failure. FOXL2-null mice showed defects in granulosa cell development during folliculogenesis. We screened a rat ovarian yeast two-hybrid cDNA library to identify FOXL2-interacting proteins and found steroidogenic factor-1 (SF-1). Here, we show that human FOXL2 and SF-1 proteins interact in human granulosa cells and that FOXL2 negatively regulates the transcriptional activation of a steroidogenic enzyme, CYP17, by SF-1. Furthermore, FOXL2 mutants found in blepharophimosis-ptosis-epicanthus inversus syndrome type I patients lost the ability to repress CYP17 induction mediated by SF-1. Chromatin immunoprecipitation and EMSA results further revealed that FOXL2 inhibited the binding of SF-1 to the CYP17 promoter, whereas the FOXL2 mutants failed to block this interaction. Therefore, this study identifies a novel regulatory role for FOXL2 on a key steroidogenic enzyme and provides a possible mechanism by which mutations in FOXL2 disrupt normal ovarian follicle development.
Insights
Mutations in FOXL2 cause blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and ovarian failure. This study reveals FOXL2 normally inhibits SF-1
Area of Science:
- Reproductive Biology
- Endocrinology
- Genetics
Background:
- Mutations in the FOXL2 gene are linked to blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) type I, characterized by premature ovarian failure in affected women.
- FOXL2 plays a crucial role in ovarian granulosa cell development and function during folliculogenesis, as evidenced by defects in FOXL2-null mice.
Purpose of the Study:
- To identify proteins interacting with FOXL2 in ovarian cells.
- To elucidate the regulatory mechanism of FOXL2 on steroidogenesis, particularly concerning the CYP17 gene.
- To investigate how FOXL2 mutations associated with BPES type I affect its interaction with SF-1 and regulation of CYP17.
Main Methods:
- Screening of a rat ovarian yeast two-hybrid cDNA library to identify FOXL2-interacting proteins.
- Co-immunoprecipitation assays to confirm the interaction between human FOXL2 and SF-1 in human granulosa cells.
- Reporter gene assays to assess the regulation of CYP17 transcriptional activation by FOXL2 and SF-1.
- Chromatin immunoprecipitation (ChIP) and Electrophoretic Mobility Shift Assay (EMSA) to analyze protein-DNA interactions at the CYP17 promoter.
Main Results:
- Steroidogenic factor-1 (SF-1) was identified as a FOXL2-interacting protein.
- FOXL2 negatively regulates SF-1-mediated transcriptional activation of the CYP17 gene in human granulosa cells.
- FOXL2 mutants associated with BPES type I lose the ability to repress SF-1-induced CYP17 expression.
- FOXL2 directly inhibits the binding of SF-1 to the CYP17 promoter, a function impaired in BPES-associated mutants.
Conclusions:
- This study identifies a novel role for FOXL2 in negatively regulating the expression of the key steroidogenic enzyme CYP17 via interaction with SF-1.
- Impaired inhibition of SF-1 binding to the CYP17 promoter by FOXL2 mutants provides a molecular mechanism for ovarian dysfunction in BPES type I.
- FOXL2's regulation of CYP17 is critical for normal ovarian follicle development and function.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Co-activators and Co-repressors
Co-activators and Co-repressors

